Dr. Gelb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bristol Myers Squibb
1000 Sierra Point Pkwy
Brisbane, CA 94005Phone+1 415-717-4342
Summary
- Accomplished Physician and Leader in Clinical Development, Translational Medicine and Pathology pharma/biotech R and D with significant therapeutic focus in antibody drug conjugates and immuno-oncology/oncology in select solid tumors and malignant hematology, and immunology. Leadership experience up to Executive Director with site head and Interim Chief Medical Officer responsibilities. Strengths include programmatic/strategic and project development, multi-site project management, clinical informatics, effective communications with physicians/ key thought leaders, in-depth health industry knowledge, superior analytical and financial skills, and significant experience as a published scientific/medical author and speaker.
Education & Training
University of California (San Francisco)Fellowship, Hematopathology, 1994 - 1995- University of California (San Francisco) School of MedicineResidency, Laboratory Medicine (Clinical Pathology), 1993 - 1994
Stanford Health CareFellowship, Immunopathology, 1991 - 1993
Stanford Health Care-Sponsored Stanford University Surgical PathologyFellowship, Selective Pathology, 1990 - 1991- Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1988 - 1990
University of ChicagoInternship, Internal Medicine, 1987 - 1988
Stanford University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1988 - 2025
FL State Medical License 2012 - 2016
NJ State Medical License 2012 - 2015- American Board of Pathology Anatomic Pathology
- American Board of Pathology Clinical Pathology
- American Board of Pathology Immunopathology
Awards, Honors, & Recognition
- Stanford Medical Scholar Stanford University, 1987
- Research Honors Award Stanford University, 1987
Clinical Trials
- A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma Start of enrollment: 2015 Jun 01
- A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer Start of enrollment: 2015 Jul 01
- A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG Start of enrollment: 2017 Sep 26
- Join now to see all
Publications & Presentations
PubMed
- 65 citationsAvelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results f...Hyun Cheol Chung, Hendrik Tobias Arkenau, Jeeyun Lee, Sun Young Rha, Do Youn Oh
Journal for Immunotherapy of Cancer. 2019-02-04 - 1423 citationsHelicobacter pylori Infection and Gastric LymphomaJulie Parsonnet, Svein Hansen, Larissa V. Rodriguez, Arnold B. Gelb, Roger A. Warnke
The New England Journal of Medicine. 1994-05-05 - 51 citationsLeu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and foll...Onsi W. Kamel, Arnold B. Gelb, R B Shibuya, Roger A. Warnke
The American Journal of Pathology. 1993-02-01
Journal Articles
- Posttransplant lymphoproliferative disorders in patients undergoing pediatric liver transplantation: a clinicopathologic study.Koh BY, Rosenthal P, Medeiros LJ. Zhou Y, Osorio RY, Roberts JP, Ascher NL, Gelb AB, Cancer
Books/Book Chapters
Press Mentions
Metabolomics and Precision MedicineApril 14th, 2019
Committees
- Delegate, Clinical and Laboratories Standards Institute 2011 - Present
Industry Relationships
- Senior Clinical Trial Physician, Bristol-Myers Squibb2020 - Present
- Executive Director, Ziopharm Oncology, Inc.Clinical Development & Medical Monitor2018 - 2020
- Senior Director, EMD Serono R&D InstituteGlobal Early Development2015 - 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
